Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Analog 23 is a promising compound for prostate cancer treatment.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Afatinib often causes skin problems that need proactive management.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Pulsed electric field treatment may help shrink untreated liver tumors.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Nanospanlastics are effective in targeted drug delivery for chronic diseases, improving skin conditions, treating hair loss, and increasing drug absorption.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Rosary Pea has medicinal benefits but requires careful handling due to its toxicity.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The combination of encorafenib and binimetinib caused few skin issues.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.